For example, "if care providers consistently screen and intervene with early-stage substance abuse, the health care system can avert enormous human and economic costs," said A. Thomas McLellan, Ph.D., deputy director of the Office of National Drug Control Policy, in testimony before a House of Representatives subcommittee on June 23.